Hänsel-Hertsch, Robert
Simeone, Angela
Shea, Abigail
Hui, Winnie W. I. http://orcid.org/0000-0001-8041-0218
Zyner, Katherine G. http://orcid.org/0000-0002-4997-0150
Marsico, Giovanni
Rueda, Oscar M. http://orcid.org/0000-0003-0008-4884
Bruna, Alejandra
Martin, Alistair
Zhang, Xiaoyun http://orcid.org/0000-0002-4132-3573
Adhikari, Santosh http://orcid.org/0000-0002-1501-2106
Tannahill, David
Caldas, Carlos http://orcid.org/0000-0003-3547-1489
Balasubramanian, Shankar http://orcid.org/0000-0002-0281-5815
Funding for this research was provided by:
Cancer Research UK (C9681/A18618, C9681/A29214, C14303/A17197, C14303/A17197, C14303/A17197, C14303/A17197, C14303/A17197, C14303/A17197, C14303/A17197, C14303/A17197, C14303/A17197, C9681/A18618, C9681/A18618, C14303/A17197, C14303/A17197)
Wellcome Trust (209441/z/17/z)
University of Cologne | Center for Molecular Medicine Cologne, University of Cologne (2635020301)
Article History
Received: 18 June 2019
Accepted: 25 June 2020
First Online: 3 August 2020
Competing interests
: S.B. is an advisor and shareholder of Cambridge Epigenetix Ltd.